1 week ago
Tempus AI (TEM) Stock Rockets 24% Following Merck-Moderna Cancer Vaccine Breakthrough
Tempus AI (TEM) stock jumped 24% after Merck-Moderna's cancer vaccine Phase 3 success validated its $1.5B Personalis acquisition and boosted investor sentiment.
The post Tempus AI (TEM) Stock Rockets 24% Following Merck-Moderna Cancer Vaccine Breakthrough appeared first on Blockonomi.
Source: Blockonomi →Related News
- 9 hours ago
The Trade Desk, Inc. (TTD) Stock: New Zuma Platform Brings Smarter AI, Simpler M...
- 9 hours ago
Laser Photonics Corporation (LASE) Stock: SOCOM Engagement Puts Counter-Drone Sy...
- 12 hours ago
Amazon (AMZN) Stock: Expands Nvidia Partnership as AI Demand Grows
- 13 hours ago
Marvell Technology (MRVL) Q2 Earnings Preview: Should Investors Buy Before Thurs...
- 13 hours ago
Nvidia (NVDA), Salesforce (CRM), CrowdStrike (CRWD), and Okta (OKTA) Soar as AI...